The National Association of Chain Drug Stores (NACDS) today submitted a statement to the U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.”


  • NACDS described the importance of direct and indirect remuneration (DIR) fee reform for reducing patients’ out-of-pocket prescription drug costs, and for pharmacies’ viability.
  • The comments also described the relationship between lower out-of-pocket drug costs and greater medication adherence – which reduces the reliance on more costly forms of care and reduces overall healthcare costs.
  • NACDS cited poll findings that demonstrate voters’ confidence in pharmacists as sources of information about how to reduce patients’ out-of-pocket drug costs.
  • Earlier this year, NACDS submitted comments to the Centers for Medicare & Medicaid Services (CMS) in support of the agency’s DIR fee reform proposal.

“CMS should use their authority to include pharmacy DIR fee reform and the movement towards a pharmacy quality incentive program in the final rule. These changes will lower out-of-pockets costs for beneficiaries and make medicine more accessible, leading to greater adherence and better health outcomes through services such as medication optimization. We urge members of the Committee to voice their concerns to Secretary of Health and Human Services and urge the inclusion of these changes in the Final Part D Rule.”

– NACDS’ statement to the House Ways and Means Committee